Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BIOCRYST PHARMACEUTICALS INC | 92,067 | reported | 27 Feb 2026 | tx 26+294,942 |
| Vanda Pharmaceuticals Inc. | 10,000 | reported | 13 Jun 2018 | tx 12+170,000 |
| IDERA PHARMACEUTICALS, INC. | 8,987 | reported | 10 Aug 2023 | tx 27+4,548,920−52,414 |
| VIROPHARMA INC | 0 | reported | 24 Jan 2014 | tx 132+2,525,891−2,788,404 |
| Spark Therapeutics, Inc. | 0 | reported | 17 Dec 2019 | tx 14+20,000−57,203 |
| Aclaris Therapeutics, Inc. | 0 | reported | 06 Jun 2025 | tx 20+186,562−17,316 |
| VERTICALNET INC | 0 | reported | 25 Jan 2008 | tx 6+34,085−1,368 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Feb 2026 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 848 | 8.75 USD | |
| 28 Nov 2025 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 783 | 7.18 USD | |
| 29 Aug 2025 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 676 | 8.31 USD | |
| 12 Jun 2025 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 12,500 | 0.00 USD | |
| 12 Jun 2025 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 27,181 | 0.00 USD | deriv |
| 06 Jun 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 4,793 | — | |
| 05 Jun 2025 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 11,580 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 42,350 | 0.00 USD | deriv |
| 06 Jun 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 4,793 | 0.00 USD | deriv |
| 30 May 2025 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 523 | 10.75 USD | |
| 28 Feb 2025 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 653 | 8.61 USD | |
| 29 Nov 2024 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 750 | 7.50 USD | |
| 30 Aug 2024 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 647 | 8.69 USD | |
| 12 Jun 2024 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 6,820 | 0.00 USD | |
| 12 Jun 2024 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 49,933 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 4,793 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 15,750 | 0.00 USD | deriv |
| 01 Jun 2024 | EXERCISE | Aclaris Therapeutics, Inc. | 4,660 | — | |
| 01 Jun 2024 | EXERCISE | Aclaris Therapeutics, Inc. | 4,660 | 0.00 USD | deriv |
| 31 May 2024 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 870 | 6.46 USD | |
| 20 May 2024 | PURCHASE | BIOCRYST PHARMACEUTICALS INC | 15,000 | 6.25 USD | first after silence |
| 29 Feb 2024 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 999 | 5.63 USD | |
| 30 Nov 2023 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 956 | 5.88 USD | |
| 31 Aug 2023 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 791 | 7.11 USD | |
| 10 Aug 2023 | SALE | IDERA PHARMACEUTICALS, INC. | 3,283 | 0.53 USD |
6 purchases reported after at least 12 months of silence — most recent on 20 May 2024.